hexamethonium has been researched along with Causalgia in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Causalgia: A complex regional pain syndrome characterized by burning pain and marked sensitivity to touch (HYPERESTHESIA) in the distribution of an injured peripheral nerve. Autonomic dysfunction in the form of sudomotor (i.e., sympathetic innervation to sweat glands), vasomotor, and trophic skin changes may also occur. (Adams et al., Principles of Neurology, 6th ed, p1359)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FOWLER, FD | 1 |
| MOSER, M | 1 |
| ROSE, JC | 1 |
| WEMPLE, JN | 1 |
2 other studies available for hexamethonium and Causalgia
| Article | Year |
|---|---|
Use of hexamethonium and dibenzyline in diagnosis and treatment of causalgia.
Topics: Cardiovascular Agents; Causalgia; Hexamethonium; Muscle Relaxants, Central; Neuralgia; Phenoxybenzam | 1956 |
Hexamethonium (C6) in the management of causalgia.
Topics: Bis-Trimethylammonium Compounds; Causalgia; Disease Management; Hexamethonium; Neuralgia | 1951 |